로딩 중…
지수 로딩 중…
SD BIOSENSOR INC.
137310· KOSPI· Health Care· Health Care Equipment & Services
₩6,840-1.72%
2026-06-19
Price Chart
SD BIOSENSOR INC.-39.20%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 825.92B KRW |
| Revenue | 718.78B KRW |
| Net Income | -471.10B KRW |
| Total Assets | 2.95T KRW |
| Net Assets | 2.37T KRW |
| Employees | 613 |
| Value | |
| P/B | 0.35x |
| P/S | 1.15x |
| FCF Yield | 36.38% |
| Profitability | |
| ROE | -19.84% |
| ROA | -16.00% |
| Op. Margin | -10.84% |
| Revenue Growth | 4.43% |
| Financial Health | |
| Debt Ratio | 124.06% |
| Total Debt | 587.08B KRW |
| FCF | 300.43B KRW |
| Cash | 184.19B KRW |
| Current Ratio | 5.07x |
| Dividend | |
| Div. Yield | 2.87% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -39.20% |
| 1M Return | -15.03% |
| From 52W High | -43.52% |
| 1Y MDD | -42.46% |
| Trading | |
| Volume | 121,106 shares |
| Foreign Own. | 6.09% |
| Per Share | |
| EPS | -3,868 KRW |
| BPS | 19,793 KRW |
Company Info
SD BIOSENSOR, established in 2010 as a spin-off from SD Co., Ltd.'s biosensor division, is a mid-sized company as of 2024. The company primarily focuses on R&D and sales of in-vitro diagnostics, including immunochemistry, molecular, point-of-care, and self-blood glucose monitoring. SD BIOSENSOR is expanding its global market and portfolio through a network of over 100 exclusive dealers, direct sales in key countries, and quality competitiveness, including WHO PQ approval. Headquartered in Suwon, Gyeonggi-do, it was founded in 2010.